<DOC>
	<DOC>NCT00034580</DOC>
	<brief_summary>This is a research study comparing the safety and efficacy of two active study medications for the treatment of bipolar I disorder.</brief_summary>
	<brief_title>Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Male or female subject, 1870 years of age Female subjects of childbearing potential must be using a medically accepted means of contraception Each subject must have a level of understanding sufficient to perform all tests and examinations required by the protocol Subjects must be considered reliable Exclusion: Female subjects who are either pregnant or nursing Uncorrected hypothyroidism or hyperthyroidism Narrowangle glaucoma Subjects who present a serious and immediate risk of endangering him or herself</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2006</verification_date>
	<keyword>Bipolar I Disorder</keyword>
</DOC>